U.S. may soon reclassify marijuana to allow medical research. What to know
PositiveHealth
- U.S. President Donald Trump is poised to sign an executive order that will reclassify marijuana from a Schedule I drug to a Schedule III substance, facilitating medical research and easing federal restrictions on cannabis. This significant change is expected to allow for the exploration of marijuana's potential medical benefits more freely.
- The reclassification is crucial as it marks a shift in the federal government's stance on marijuana, which has long been viewed as a dangerous substance alongside drugs like heroin. This move could pave the way for increased research into medical applications of cannabis, potentially leading to new treatments and products.
- This development reflects a broader trend in U.S. drug policy, where there is growing recognition of the medicinal properties of marijuana. The reclassification may also influence ongoing debates about drug regulation and public health, particularly in light of the challenges posed by the opioid crisis and the need for alternative pain management solutions.
— via World Pulse Now AI Editorial System
